Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
about
EndothelinVascular endothelin receptor type B: structure, function and dysregulation in vascular diseaseEndothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide.Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery diseaseEndothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans.Role of endothelin in human hypertension.Participation of renal and circulating endothelin in salt-sensitive essential hypertension.Role of the endothelin axis and its antagonists in the treatment of cancerRole of endothelin in regulation of resistance, fluid-exchange, and capacitance functions of the systemic circulation.Anti-hypotensive treatment and endothelin blockade synergistically antagonize exercise fatigue in rats under simulated high altitudeEnhanced endothelin-1 system activity with overweight and obesityAcute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart diseaseDirect comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography.Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence.Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1.Vasoactive peptides in cardiovascular (patho)physiology.Role of endothelin in microvascular dysfunction following percutaneous coronary intervention for non-ST elevation acute coronary syndromes: a single-centre randomised controlled trialVasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.Smooth muscle specific disruption of the endothelin-A receptor in mice reduces arterial pressure, and vascular reactivity and affects vascular development.Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects.Insulin and endothelin in the acute regulation of adiponectin in vivo in humans.Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men.Responses to neither exogenous nor endogenous endothelin-1 are altered in patients with hypercholesterolemia.Endothelin-1 Regulation of Exercise-Induced Changes in Flow: Dynamic Regulation of Vascular Tone.
P2860
Q26767156-73445CA0-03FB-4624-B032-F82185063984Q28263963-B9054647-753C-4EFB-AD57-AEB6AA7FD8AEQ31063102-A19EB5AD-5DEA-43A3-B1DD-2372C31ECA33Q31110191-B19AC2B9-2B1C-4516-A3DB-2693FC0B870DQ33293919-15DEF310-E224-41C9-8669-5C698992702EQ34210942-9E058022-E9B2-4B7B-9B43-81FE48B30108Q34702439-A1F03BAB-7115-43BC-A6E9-8F789A9691CEQ34919570-B00DDC1A-916D-4EBE-BCB4-D6D462E9E586Q35168398-A1A27727-D593-413A-B86B-4A2D708DE1F0Q35194035-1922F099-06B4-4A03-B32E-1D95BF428475Q35314860-B6843484-EADE-4C94-BD16-C3DB2F30532AQ35581586-8E936679-0486-4B1E-BC9D-77F8BF7A32F3Q35584359-B5823802-4950-4F06-9A90-C40EB2910647Q35595423-DFE61FF5-A26B-4DB1-87ED-5992BBB81E8DQ35768938-149B3D16-9F2C-4330-9E4B-EDB437117E49Q35826845-340E800B-A4FA-4F1E-B7F4-534C375998EDQ36163574-7B764432-1572-42B8-ADFC-5E5D2E30F571Q36764714-A93BF36C-B53A-4FEE-965C-A57D6563D472Q36815987-710BF8AC-391B-460B-A269-3C95A1932D34Q37156436-9A1D3AFA-FA29-4E23-9BB9-1CC3CED87984Q42283997-0E4D98D8-C5F1-4D36-9740-3A00D57C940FQ42725612-D5CDFE3A-72D3-47D9-A031-1B7566C1D05DQ42829416-CCD8EDF3-7CA0-4BB8-B20C-EE99097CB37AQ46091583-AD607818-B132-4E1E-BD0E-770651CAC1DDQ46440391-CA158BF1-E173-4DBD-BA77-FAC18C1856B5Q46587342-CC9E6EC0-A7D0-4799-8AA0-EA14B11158DFQ46715356-5BD88952-F497-47F1-9D94-95B3B3EF980FQ47167424-EBC2DC1F-396D-452A-B7C2-4F4AEE2A248E
P2860
Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Systemic ETA receptor antagoni ...... lar resistance in healthy men.
@en
Systemic ETA receptor antagoni ...... lar resistance in healthy men.
@nl
type
label
Systemic ETA receptor antagoni ...... lar resistance in healthy men.
@en
Systemic ETA receptor antagoni ...... lar resistance in healthy men.
@nl
prefLabel
Systemic ETA receptor antagoni ...... lar resistance in healthy men.
@en
Systemic ETA receptor antagoni ...... lar resistance in healthy men.
@nl
P2093
P2860
P356
P1476
Systemic ETA receptor antagoni ...... ular resistance in healthy men
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0704304
P407
P577
2001-10-01T00:00:00Z